Active ingredients from natural botanicals in the treatment of obesity

Obesity Reviews

Volumn 15, Issue 12, 2014, Pages 957-967

  Zhang, W L ^a   Zhu, L ^a   Jiang, J G ^a  

^a SOUTH CHINA UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

Active ingredients; Obesity; Traditional Chinese medicine; Treatment

Indexed keywords

ALKALOID; ANTIOBESITY AGENT; ASIMILOBINE; ASTRAGALOSIDE IV; BERBERINE; BETAINE; CAPSAICIN; EMODIN; FLAVONOID; GENIPOSIDE; GLYCYRRHIZIC ACID; ISOFLAVONE; LINOLENIC ACID; MAGNOLOL; MATRINE; PHENOL DERIVATIVE; PIPERINE; POLYSACCHARIDE; RESVERATROL; RUTAECARPINE; SALIDROSIDE; SAPONIN; URSOLIC ACID; HERBACEOUS AGENT; POLYPHENOL;

ARTICLE; ATTENUATION; CALORIC INTAKE; CHINESE MEDICINE; COMORBIDITY; DIGESTION; DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM; DRUG EFFICACY; ENERGY EXPENDITURE; HUMAN; LIPID ABSORPTION; LIPID METABOLISM; LIPID OXIDATION; LIPOGENESIS; OBESITY; SATIETY; APPETITE; DRUG EFFECTS; INTESTINE ABSORPTION; PHYTOTHERAPY;

ALKALOIDS; ANTI-OBESITY AGENTS; APPETITE; DIGESTION; DRUGS, CHINESE HERBAL; ENERGY INTAKE; HUMANS; INTESTINAL ABSORPTION; OBESITY; PHYTOTHERAPY; POLYPHENOLS; POLYSACCHARIDES; SAPONINS; SATIATION;

EID: 84912035331     PISSN: 14677881     EISSN: 1467789X     Source Type: Journal    
DOI: 10.1111/obr.12228     Document Type: Article

References (113)

1. Alam I, Lewis K, Stephens JW, Baxter JN. Obesity, metabolic syndrome and sleep apnoea: all pro-inflammatory states. Obes Rev 2007; 8: 119-127.
2. Altunkaynak BZB, Özbek E. Obesity: causes and treatment alternatives. Dicle Ti{dotless}p Dergisi 2007; 34: 144-149.
3. Roth J, Qiang XL, Marbán SL, Redelt H, Lowell BC. The obesity pandemic: where have we been and where are we going? Obes Res 2004; 12: 88s-101s.
4. Kelly T, Yang W, Chen CS, Reynolds K, He J. Global burden of obesity in 2005 and projections to 2030. Int J Obes 2008; 32: 1431-1437.
5. Hill JO, Wyatt HR, Reed GW, Peters JC. Obesity and the environment: where do we go from here? Science 2003; 299: 853-855.
6. Shi YG, Burn P. Lipid metabolic enzymes: emerging drug targets for the treatment of obesity. Nat Rev Drug Discov 2004; 3: 695-710.
7. Fang YY. Hyperinsulinemia and obesity. J Hubei Sport Sci 2006; 25: 33-34.
8. Wang CR, Yang XR. The physiological analysis of etiology of obesity. J Beijing Univ Physical Educ 1994; 17: 39-45.
9. Bluhre M. Adipose tissue dysfunction in obesity. Exp Clin Endocr Diab 2009; 117: 241-250.
10. Phillips CM. Metabolically healthy obesity: definitions, determinants and clinical implications. Rev Endocr Metab Dis 2013; 14: 219-227.
11. Ota T. Chemokine systems link obesity to insulin resistance. Diabetes Metab J 2013; 37: 165-172.
12. Weyer C, Funahashi T, Tanaka S etal. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001; 86: 1930-1935.
13. Lichtash CT, Cui J, Guo X etal. Body adiposity index vs. body mass index and other anthropometric traits as correlates of cardiometabolic risk factors. PLoS ONE 2013; 8: e65954.
14. Bray GA, Clearfield MB, Fintel DJ, Nelinson DS. Overweight and obesity: the pathogenesis of cardiometabolic risk. Clin Cornerstone 2009; 9: 30-40.
15. Must A, Spadano J, Coakley EH etal. The disease burden associated with overweight and obesity. JAMA 1999; 282: 1523-1529.
16. Louie SM, Roberts LS, Nomura DK. Mechanisms linking obesity and cancer. BBA-Mol Cell Biol L 2013; 1831: 1499-1508.
17. Simonyi G, Pados G, Medvegy M, Bedros JR. The pharmacological treatment of obesity: past, present and future. Orv Hetil 2012; 153: 363-373.
18. Khan A, Raza S, Khan Y etal. Current updates in the medical management of obesity. Recent Pat, Endocr Metab Imm Drug Discov 2012; 6: 117-128.
19. Gadde KM, Allison DB, Ryan DH etal. Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial. Lancet 2011; 377: 1341-1352.
20. Di Dalmazi G, Vicennati V, Pasquali R, Pagotto U. The unrelenting fall of the pharmacological treatment of obesity. Endocr 2013; 44: 598-609.
21. Hurt RT, Edakkanambeth Varayil J, Ebbert JO. New pharmacological treatments for the management of obesity. Curr Gastroenterol Rep 2014; 16: 394-401.
22. Kabra DG, Kabra UD, Tschöp MH, Hofmann S. Pharmacological treatment of obesity. Sleep Loss and Obesity: Intersecting Epidemics 2012: 203-225.
23. Astrup A, Rössner S, Van Gaal L etal. Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study. Lancet 2009; 374: 1606-1616.
24. Sui Y, Zhao HL, Wong VCW etal. A systematic review on use of Chinese medicine and acupuncture for treatment of obesity. Obes Rev 2012; 13: 409-430.
25. Wang AZ. Analysis of treatment on simple obesity by traditional Chinese medicine. Med Lab Sci 2013; 8: 123-124.
26. Luo CJ, Sun YL. Research progress in the treatment of simple obesity of traditional Chinese medicine. Mod J Integr Trad Chin West Med 2010; 19: 3482-3484.
27. Liu DL, Dong YJ. Research progress in effect mechanism on simple obesity by traditional Chinese medicine. Chin J Clin Ration Drug 2010; 3: 143-144.
28. Li WF, Jiang JG, Chen J. Chinese medicine and its modernization demands. Arch Med Res 2008; 39: 246-251.
29. Skene CD, Sutton P. Saponin-adjuvanted particulate vaccines for clinical use. Methods 2006; 40: 53-59.
30. Augustin JM, Kuzina V, Andersen SB, Bak S. Molecular activities, biosynthesis and evolution of triterpenoid saponins. Phytochemistry 2011; 72: 435-457.
31. Birari RB, Bhutani KK. Pancreatic lipase inhibitors from natural sources: unexplored potential. Drug Discov Today 2007; 12: 879-889.
32. Lin JC, Cen BH, Jiang WN etal. Progress in lipid-lowering by active ingredients of traditional Chinese medicine. Chin Med Mod Dist Edu China 2013; 11: 164-165.
33. Luo Q, OuYang LB. Anti-obesity effect of glycyrrhizin on obese rats and its mechanism. Centr S Pharm 2010; 8: 204-208.
34. Xie WD, Cai GP, Zhang YO etal. Macrostemonoside A: a novel compound for hypoglycemic, lipid-lowering and anti-obesity. Dev Pharm Pharmacol PhD Forum 2008; 1: 97-98.
35. Agrawal PK. NMR spectroscopy in the structural elucidation of oligosaccharides and glycosides. Phytochemistry 1992; 31: 3307-3330.
36. Ooi VEC, Liu F. Immunomodulation and anti-cancer activity of polysaccharide-protein complexes. Curr Med Chem 2000; 7: 715-729.
37. Zhong XL, Ding JL, Luo DS. Progress on blood lipid-regulating active ingredients from traditional Chinese medicine. Food & Drug 2010; 11: 449-451.
38. Ning N, Han JJ. Advances in studies on active components of reducing blood lipid in traditional Chinese medicine. Asia-Pac Tradit Med 2013; 9: 76-79.
39. Zhang M, Zhu CP, Shi CL, Xiao JX, Zhang SH. Extraction, isolation of Lycium barbarum polysaccharide-4 and its role in weight loss obesity mice on female hypothalamus injury. Nutr Health 2003; 24: 114-117.
40. Gao XX, Meng XJ, Li JH. Study on functions of active polysaccharide from Schisandra chinensis (Turcz) Baill in reducing weight and fat. Sci Technol Food Ind 2008; 29: 248-251.
41. Bai YL Studies on the effect of Elaeagnus angustifolia polysaccharide on reducing blood lipid and slimming and antioxidant in rats. MSc Thesis, Jilin University, Changchun, Jilin, China, 2007.
42. Cordell GA, Quinn-Beattie ML, Farnsworth NR. The potential of alkaloids in drug discovery. Phytother Res 2001; 15: 183-205.
43. Vichasilp C, Nakagawa K, Sookwong P etal. Optimization of 1-deoxynojirimycin extraction from mulberry leaves by using response surface methodology. Biosci Biotech Bioch 2009; 73: 2684-2689.
44. Lu X, Wang J, Wang H etal. Effects of betaine on body weight and biochemical index in obese rats fed with high-fat diet. J Nutr 2008; 30: 311-312, 315.
45. Zhang ZG, Meng XJ, Li B etal. The study on the effect and mechanism of berberine of promoting the energy expenditure of the body and the therapeutic of obesity. J Diabetes Mellitus 2012; 4: 136.
46. Wang SH, Wang WJ, Wang XF, Chen WH. Effect of Astragalus polysaccharides and berberine on carbohydrate metabolism and cell differentiation in 3T3-L1 adipocytes. Chin J Integr Med 2004; 24: 926-928.
47. Arts ICW, Hollman PCH. Polyphenols and disease risk in epidemiologic studies. Am J Clin Nutr 2005; 81: 317S-325S.
48. Scalbert A, Johnson IT, Saltmarsh M. Polyphenols: antioxidants and beyond. Am J Clin Nutr 2005; 81: 215S-217S.
49. Mei L, Zheng PY, Yuan JL. Probiotics and traditional Chinese medicines for the improvement of obesity: research progress. Chin J Microecol 2013; 25: 233-237.
50. Liang WW, Yan J, Wu LH, Fan CL. Effect of hawthorn leaf flavonids on lipid metabolism in hyperlipidemia rats. Health Res 2010; 8: 8-11.
51. Chen SF, Xiao XC, Sun YS, Zheng L, Feng X. Effects and mechanisms of resveratrol on proliferation and differentiation of murine 3T3-L1 cells. Chin Pharmacol Bull 2010; 26: 108-111.
52. Shen JZ The effect of pentylmethyl quercetin in metabolic syndrome mice due to intervention of monosodium glutamate. MSc, Huazhong University of Science and Technology, Wuhan, China, 2009.
53. Shi L, Sun J, Li L etal. Antiobesity effects of geniposide on monosodium glutamate-induced obese mice. China pharm 2011; 22: 3671-3673.
54. Wang SK, Sun GJ, Han C etal. Study on the effect and mechanism on losing weightof Lycium barbarum polysaccharide. 2nd Conference 4th CST Food Toxicology Comm: Zhejiang Hangzhou, China, 2006, pp. 258-260.
55. Liu CY, Chen H, Wang L etal. Effects of total saponins from bd on striatum extracellular levelsi of 5-HT and 5-HIAA in the diet-induced obese rats. J Nongken Med 2011; 33: 139-143.
56. Loftus TM, Jaworsky DE, Frehywot GL etal. Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors. Science 2000; 288: 2379-2381.
57. Du YT, Wang X, Wu XD, Tian WX. Keemun black tea extract contains potent fatty acid synthase inhibitors and reduces food intake and body weight of rats via oral administration. J Enzym Inhib and Med Chem 2005; 20: 349-356.
58. Mukherjee PK, Maiti K, Mukherjee K, Houghton PJ. Leads from Indian medicinal plants with hypoglycemic potentials. J Ethnopharmacol 2006; 106: 1-28.
59. Zhang Z. The inhibition of tea polyphenol on pancreatic lipase. Food Ind 2013; 34: 168-170.
60. Zheng YN, Liu KY, Xu BJ, Han LK. Studies on effects of platycodi radix on lipid metabolism of mice with high fat diet-induced obesity. J Jilin Agr Univ 2002; 24: 42-46, 53.
61. Wang SH, Wang WJ, Wang XF, Chen WH. Effects of salidroside on carbohydrate metabolism and differentiation of 3T3-L1 adipocytes. Chin J Integr Med 2004; 2: 193-195.
62. Wang HM, Sun W, Huang SX, Xiang WL. Experimental study on weight-losing and hypolipidemic effects of thalluslamina riae polysaccharides and its mechanisms in rat. Chin JMAP 2008; 25: 16-19.
63. Zhao M, Ji QY, Yan M, He HS. Study advances of Portulaca oleracea L.with hyperlipidemia-lowering actions. J Jiangxi Univ Tradit Chin Med 2011; 23: 99-100.
64. Wu GZ, Guo YQ, Su X, Yang HX, Zhang J. Studies on the antiobesity action and mechanisms of daidzein derivative: LRXH609. Chin J Clin Pharmacol Ther 2009; 14: 519-523.
65. Xie F, Liu YY, Li XY. Influence of Astragaloside IV on reduction of body weight of mice. J Liaoning Univ TCM 2013; 15: 233-234.
66. Deng HC, Liu DF. Obesity and lipid metabolism. J Clin Dept Intern Med 2003; 20: 116-118.
67. Viardot A, Heilbronn LK, Samocha-Bonet D etal. Obesity is associated with activated and insulin resistant immune cells. DM Res Rev 2012; 28: 447-454.
68. Kalupahana NS, Moustaid-Moussa N, Claycombe KJ. Immunity as a link between obesity and insulin resistance. Mol Aspects Med 2012; 33: 26-34.
69. Guo Z, Yuan LJ, Lu X etal. Effects of magonol on body weight and insulin resistance of fat-rich food-fed obese rats. Basic & Clin Med 2008; 28: 936-939.
70. Liu YX. Rsearch on the anti-obesity effect of ursolic acid with experimental hyperlipidemia mice. W China J Pharm Sci 2013; 28: 264-266.
71. Sergent O, Pereira M, Belhomme C etal. Role for membrane fluidity in ethanol-induced oxidative stress of primary rat hepatocytes. J Pharmacol Exp Ther 2005; 313: 104-111.
72. Yuan LJ, Lu X, Wang J etal. Effects of matrine on weight, serum lipids and anti-oxidative capacity in high-fatted rats. Lishizhen Med Mater Med Res 2008; 19: 2062-2064.
73. Zhang Y, Zhang XD. In the pathogenesis of obesity and its treatment of traditional Chinese medicine. Inf Tradit Chin Med 2007; 24: 13-15.
74. Wang XJ, Sun H, Zhang AH etal. Potential role of metabolomics apporoaches in the area of traditional Chinese medicine: as pillars of the bridge between Chinese and Western medicine. J Pharmaceut Biomed 2011; 55: 859-868.
75. Zhou B. Research progress of traditional Chinese medicine in the treatment of obesity. Inner Mongolia J Tradit Chin Med 2012; 9: 90-91.
76. Li S, Zou X, Deng TT. Progress of studies of obese on mechanism and treatment by traditional Chinese medicine. Chin J Integr Med Cerebr Dis 2004; 2: 657-659.
77. Liu HR. The summaries on the effect of bio-active components from natural products therapy for hyperl ipidemia. Hunan J TCMP 2002; 12: 742-745.
78. Yang CY, Xie ZG, Cheng WB, Jiang X, Chen ZH. Effects of Panax notoginseng saponins on anti-hyperglycemic, anti-obese and prevention from kidney pathological changes in KK-Ay mice. J Chin Med Mater 2009; 32: 1571-1576.
79. Kang JK, Gao CJ, Ma KQ, Hao JJ, Wang ZQ. Effects of Panax notoginseng saponins on diet induced metabolic dysfunction and expression of inflammatory cytokines in adipose tissue of obese mice. J Chongqing Med Univ 2012; 37: 949-953.
80. Liu F, Chen H, Zhong M etal. Effects of total saponins of Medicago sativa on blood lipid metabolism in rats with experimental hyperlipidemia. Chin J Exp Trad Med Formul 2011; 17: 211-214.
81. Lu FR, Qin Y, Shen L, Xiong PC, Yu L. Effect of Trigonella foenum-graecum saponin on blood glucose and lipid metabolism and insulin resistance in diet-induced obese rats. Chi J Inform TCM 2010; 17: 34-36.
82. Chen JP. Experimental study on the effect of weight lose of Astragalus saponin. Heilongjiang JTCM 2011; 1: 49-50.
83. Niu W, Qu WJ, Wang YF etal. Effects of saponins from Tribulus terrestris L. on insulin resistance and hyperlipidemia in the diet-induced obese rats. Acta Nutrim Sin 2006; 28: 170-173.
84. He YZ. Anti-obesity effect of total saponins of Gypsophila water portion. Foreign Med Sci 2005; 27: 185-186.
85. Lu H, Long ZJ, Zhang DF. Effects of sapindoside on blood lipid metabolism and its protective action on vascular endothelial function in hyperlipidemic rat. Chin Pharm 2011; 20: 14-15.
86. Lei RJ, Li J, Jin SX etal. Hyperlipidemic effect of total steroidal saponins extracted from Allium chinense G. Don in high-fat diet-induced hyperlipidemia rats. Chin Tradit Pat Med 2013; 35: 1615-1619.
87. Sui DY, Han CC, Yu XF, Qu SC. Effects of Acanthopanax senticosus saponins on blood lipid metabolism and antioxidative activity in experimental hyperlipidemia rats. J Jilin Univ (Med) 2004; 30: 56-59.
88. Chen WQ, Luo SH, Li HZ, Yang H. Comparative studies on pharmacological effects of the main chemical constituents of Peucedanum praeruptorum from Henan and Jiangxi. China J Chin Mater Med 2005; 30: 1358-1360.
89. Wang HM, Xia DZ, Xiang M, Xiang WL, Pan HM. Research of lentinan's effect on blood lipid and its mechanisms. Zhejiang JITCWM 2005; 15: 599-602.
90. Yang XH, Zhou YM, Zhang Y etal. Effect study of Auricularia polysaccharide on reducing blood lipid. Mod Food Sci Technol 2010; 21: 1381-1382.
91. Zhou GH, Yu GP. Effect study of Auricularia polysaccharide on reducing blood lipid. Mod Food Sci Technol 2005; 21: 46-48.
92. Huang W Studies on antilipemic function and mechanism of Opuntia dillenii haw. polysaccharide. MSc, Hunan Agricultural University, Changsha, China, 2008.
93. Chen LQ, Huang Q, Liu XQ. Reducing blood lipid in rats of Se konjac, garlic polysaccharide. Chin J Publ Health 2009; 25: 1402-1403.
94. Zhang TT, Xia XK, Chen CP etal. Biological activities of polysaccharides from Polygonatum sibiricum redoute. Chin J Exp Tradit Med Formul 2006; 12: 42-45.
95. Wang XY, Seliman MS, Li L. Effect on the levels of serum total cholesterol of the rats of blackcurrant polysaccharides. China Foreign Med 2010; 23: 41.
96. Li JP, Jiang H, Liu MX. Study on weight loss and antioxidation of Isatis root polysaccharide. 9th Natl Congr Chin Pharmacol Inst: Wuhan, China, 2007; 26: 58.
97. Fan TT Study on lipid-lowing and weight-loosing activity of alkaloids from lotus leaf. MSc, Zhejiang University, Hangzhou, China, 2013.
98. Wu E, Zhou HF, Han SY. Comparative study on hypolipidemic effect of piperine and methyl piperate from piper longum's extract. Med J West China 2013; 25: 1146-1147.
99. Zhang L, Liu X, Chen ZD. Advance in research of hypolipidmic efficacy and mechanisms of. Manag Res Boost Food Saf Chongqing Summ Forum 2011; 6: 466-469.
100. Nie XQ, Yu LH, Chen HH, Zhao TF, Bian C. Intervention effect on type2 diabetes in obese rats of rutaecarpine. Chin Pharmacol Bull 2010; 26: 872-876.
101. Shi HL, Zheng QL, Wu DZ. Effect on anti-obesity complicated with vascular hypertrophy of rutaecarpine. Chin Pharmacol Bull 2011; 27: 1687-1692.
102. Cheng JY, Zhang XL, Yang Y, Shen XY, Zhang CB. Effects of baicalein on differentiation of 3T3-L1 preadipocytes into adipocytes and on fatty acid synthase activity. Nat Prod Res Dev 2004; 16: 7-9.
103. Yin RQ, Ding Y, Chen MD, Ju ML, Huang SS. Research on the inhibition mechanism of baicalin on pancreatic lipase. J Anhui Agri 2009; 37: 11534-11536.
104. Ge XZ, Lin Q, Huo Q, Li E. Effects of soybean isoflavones and hawthorn compound on thrombosis in rats with hyperlipidemia. Pharmacol Clin 2006; 22: 42-43.
105. Wang ZY, Zhou LP, Liu Y. Effect of apple polyphenol on lipid metabolism in mice. Food Sci 2010; 31: 288-291.
106. Han C, Fan XB, Wang SK, Liu S, Li H. Experimental study of EGCG on weight loss in obese rats. Mod Med J 2008; 36: 197-199.
107. Zhao YM, Li FZ, An XN, Zhou MY. Study of phillyrin on weight loss in nutritive obesity mice. Nat Prod Res Dev 2007; 19: 277-279.
108. Zuo GM, Tan C, Wang JH, Qin LK. Effect of buckwheat protein on reducing blood lipid and antioxidant in hyperlipemia mice. Food Sci 2010; 31: 247-250.
109. Zhang CB, Teng L, Shi Y etal. Effect of emodinon proliferation and differentiation of 3T3-L1 preadipocyte and FAS activity. Chin Med J 2002; 115: 75-78, 150.
110. Luo XQ, Xu XY, Huang CG etal. Effect of total anthraquinones in semen cassiae on oxidation of liver lipid in rats with alcoholic fatty liver and PPAR-γ expression. China J Chin Mater Med 2011; 36: 1654-1659.
111. Li LC, Wu XD, Tian WX. Inhibition to fatty acid synthase with extract of tuber fleeceflower root. Chin J Biochem Mol 2003; 19: 297-304.
112. Wang H, Li W, Cui SK etal. Protection of anthraquinone of Rhizoma Polygoni Cuspidati for kidneys of early diabetic nephropathy model rats. Chin J Exp Tradit Med Form 2011; 17: 169-171.
113. Guo ML, Zhou YP, Feng X. Experimental study on the hypolipidemic effect of auxiliary Eucommia seed oil. China Prev Med 2008; 9: 677-678.